Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
53 studies found for:    "cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy" OR "Cerebral Arterial Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Methods of Etiological Diagnosis of Cerebral Amyloid Angiopathy
Conditions: Cerebral Amyloid Angiopathy;   Intracerebral Hemorrhage
Intervention:
22 Not yet recruiting Superiority of Rt-PA + Tenecteplase in Comparison With Rt-PA Only in Proximal Middle Cerebral Artery Occlusion
Conditions: Nervous System Disorders;   Cerebral Artery
Interventions: Drug: rt-PA;   Drug: tenecteplase
23 Unknown  Subclavian Vein catheterization_Seldinger Vs Modified Seldinger
Conditions: Brain Neoplasm;   Intracranial Aneurysm;   Cerebrovascular Moyamoya Disease
Interventions: Procedure: Seldinger technique;   Procedure: Modified Seldinger technique
24 Unknown  Moyamoya Disease Biomarkers in Patients With Intracranial Atherosclerotic Stroke
Conditions: Moyamoya Disease;   Intracranial Atherosclerotic Stroke;   Intracranial Steno-occlusive Disease
Intervention:
25 Recruiting Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
Condition: CADASIL
Intervention:
26 Enrolling by invitation Generation of a Cellular Model of CADASIL From Skin Fibroblasts
Condition: CADASIL
Intervention: Other: Skin biopsy
27 Terminated Thrombectomy Under Reopro Versus Alteplase to Treat Stoke
Condition: Infarction, Middle Cerebral Artery
Interventions: Procedure: abciximab IV and thrombectomy;   Drug: alteplase 0.9mg/kg (10% by IV bolus following by 90% by 1 hour IV drip)
28 Terminated Hemicraniectomy for Malignant Middle Cerebral Artery Infarction (HeMMI): A Single Center Randomized Controlled Clinical Trial
Condition: Infarction of the Middle Carotid Artery Territory.
Interventions: Procedure: Hemicraniotomy;   Procedure: Standard medical treatment
29 Terminated A Study to Evaluate the Efficacy and Safety of Piracetam on Aphasia After Acute Ischemic Cerebral Artery Stroke
Condition: Acute Ischaemic Middle Cerebral Artery Stroke
Interventions: Drug: Piracetam;   Other: Placebo
30 Completed Impact of tDCS on Cerebral Autoregulation
Conditions: Cerebral Microangiopathy;   CADASIL;   Migraine With Aura;   ICA Stenosis
Interventions: Device: Anodal tDCS;   Device: Cathodal tDCS;   Device: sham tDCS
31 Active, not recruiting Superficial Siderosis in Patients With Suspected Cerebral Amyloid Angiopathy
Conditions: Intracerebral Hemorrhage;   Cerebral Amyloid Angiopathy;   Ischemic Stroke
Intervention:
32 Recruiting The Carotid and Middle Cerebral Artery Occlusion Surgery Study
Conditions: Carotid Artery Occlusion;   Middle Cerebral Artery Occlusion;   Stroke
Interventions: Procedure: bypass surgery;   Drug: Aspirin;   Drug: Clopidogrel
33 Recruiting Autologous Bone Marrow Stromal Cell and Endothelial Progenitor Cell Transplantation in Ischemic Stroke
Conditions: Stroke;   Infarction, Middle Cerebral Artery
Interventions: Genetic: Autologous BMSCs transplantation;   Genetic: Autologous EPCs transplantation;   Genetic: IV infusion of placebo
34 Recruiting Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct
Condition: Middle Cerebral Artery Infarction
Interventions: Other: Standard medical care;   Biological: Autologous bone marrow-derived mesenchymal stem cells
35 Unknown  Study of Purified Umbilical Cord Blood CD34+ Stem Cell on Chronic Ischemic Stroke
Conditions: Ischemic Stroke;   Ischaemic Cerebral Infarction;   Infarction, Middle Cerebral Artery;   Ischemia;   Brain Ischemia
Intervention: Procedure: Intercerebral implantation of allogenic CD34+ stem cell
36 Completed Quantifying Collateral Perfusion in Cerebrovascular Disease-Moyamoya Disease and Stroke Patients
Conditions: Cerebrovascular Accident;   Moyamoya Disease
Intervention: Drug: Xenon as contrast agent
37 Withdrawn F-18-AV-45 Uptake, Spot Sign Presence and Cerebral Amyloid Angiopathy (CAA) in Primary Intracranial Hemorrhage (ICH)
Condition: Cerebral Amyloid Angiopathy
Intervention:
38 Unknown  Safety Study of Dabigatran in CADASIL
Condition: CADASIL
Interventions: Drug: Dabigatran;   Drug: Antiplatelets
39 Unknown  Implantation of Olfactory Ensheathing Cells (OECs)
Conditions: Infarction, Middle Cerebral Artery;   Ischemic Stroke,;   Stroke With Hemiparesis,;   Thromboembolic Stroke.
Intervention: Procedure: Olfactory ensheathing cells
40 Terminated Study of Human Placenta-derived Cells (PDA001) to Evaluate the Safety and Effectiveness for Patients With Ischemic Stroke
Conditions: Stroke, Acute;   Middle Cerebral Artery Stroke;   Posterior Cerebral Artery Stroke
Interventions: Biological: Human Placenta-Derived Cells PDA001- (cenplacel-L);   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-53) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.